Market Overview

CHA-Hollywood Presbyterian Medical Center at the Forefront of Robotic Surgical Technology


A cutting-edge, minimally invasive, new surgical technology optimized
for complex procedures in the areas of gynecology, urology, thoracic
surgery and surgical oncology

CHA-Hollywood Presbyterian Medical Center (CHA-HPMC), a subsidiary of
CHA Bio Group (a Korea-based global leader in bio-technology and health
care) has introduced its latest addition, da Vinci Xi Surgical
System. CHA-HPMC will be the first community medical center in the area
(Hollywood, Korea Town, Los Feliz, and Silver Lake) to offer this
advanced surgical system, which optimizes clinical outcomes and patient
experience — while minimizing surgical invasiveness and the length of
hospital stay.

"Bringing this multi-million dollar robotic surgery program to CHA-HPMC
is a first critical step towards achieving our long-term vision of
becoming a premiere medical center," said Dr. Joung H. Lee, a
neurosurgeon and Chief Administrative Officer at CHA-HPMC, who was
recruited from the Cleveland Clinic after his 21-year tenure.

CHA-HPMC is not the only affiliate of the CHA Bio Group to utilize this
technology. CHA Bio Group first introduced the robotic surgical system
at its CHA Bundang Medical Center in 2013. Since its inception, over
3,400 surgical procedures were successfully conducted in the specialties
of gynecology, urology, thoracic surgery, and surgical oncology.

Earlier this year, CHA-HPMC embarked on its $400 million master plan
slated for completion by the end of 2020. Part of this plan are 2 new
buildings: A 5-story patient tower equipped with the latest technology,
10-story building with 7 floors for parking, and top 3 floors dedicated
for medical office spaces. Along with the campus expansion, strategic
plans are in place to recruit world-class specialists in various areas,
to fulfill the CHA Bio Group's commitment to provide the highest quality
care to our entire community and beyond.

Find out more about robotic surgery at

About CHA-Hollywood Presbyterian Medical Center

CHA-HPMC has been an indispensable partner and resource within the
Hollywood community since its founding in 1924. It is a community-based,
safety-net, general acute care hospital with 434-licensed beds and
operates intensive care unit, telemetry unit, acute rehabilitation unit,
labor and delivery/obstetrics unit, 24-hour emergency department,
surgical operating rooms, and 89-bed skilled nursing facility. Its
diverse medical staff, which pledges quality care with compassion and
respect, includes more than 500 physicians in 69 specialties —
representing over 75 countries. With a workforce of more than 1,300
employees, CHA-HPMC is one of Hollywood's Top-10 employers.

CHA-HPMC has been nationally recognized with the following quality
awards from Healthgrades: Patient Safety, Labor and Delivery, Obstetrics
and Gynecology, Back Surgery, Hip Fracture Treatment, and Treatment of
Heart Failure.

About CHA Bio Group

CHA Bio Group (,
headquartered in Pan-gyo, Korea, is a global leader in the biotechnology
industry, consisting of 25 hospitals & clinics, 27 research & 7
education institutions, and 28 bio/pharmaceutical/healthcare companies.
Its healthcare subsidiary, CHA Health Systems, delivers world-class care
in all facets of medicine — famous particularly for its research and
clinical work in the fields of fertility and cutting edge therapies
using cord blood stem cells and immune cells.

View Comments and Join the Discussion!